StockMacro
Menu

Fortrea

$18.55 +40% in 6 monthsMarket cap $1.8B

FTRE on XNAS, Health Care, Fortrea Holdings Inc., job postings

Measures activity, not value. Not investment advice.

Shares up 85% in a year but revenue fell 3.4% and the company lost $68.7M.

  • WatchShares fell 23% in one month, after rising 40% over six months
  • BadShort interest 8.9% of shares, up 12% in two weeks

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Industry
Services-medical laboratories (Health Care)
Employees
14,000
Website
fortrea.com
Listed
Nasdaq, US
Last results
29 Oct 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $691.5M, net income $600K.
Quarter to 31 Mar 2022: revenue –, net income $32.5MQuarter to 30 Jun 2022: revenue $793.1M, net income $66.4MQuarter to 30 Jun 2022: revenue $793.1M, net income $66.4MQuarter to 30 Sep 2022: revenue $762.3M, net income $60.6MQuarter to 30 Sep 2022: revenue $762.3M, net income $60.6MQuarter to 31 Dec 2022: revenue $761.7M, net income $33.4MQuarter to 31 Dec 2022: revenue $761.7M, net income $33.4MQuarter to 31 Mar 2023: revenue $693.9M, net income $17.4MQuarter to 31 Mar 2023: revenue $693.9M, net income $17.4MQuarter to 30 Jun 2023: revenue $793.0M, net income $28.3MQuarter to 30 Jun 2023: revenue $793.0M, net income $28.3MQuarter to 30 Sep 2023: revenue $776.4M, net income -$13.1MQuarter to 30 Sep 2023: revenue $776.4M, net income -$13.1MQuarter to 31 Dec 2023: revenue $775.4M, net income -$36.0MQuarter to 31 Dec 2023: revenue $775.4M, net income -$36.0MQuarter to 31 Mar 2024: revenue $662.1M, net income -$101.0MQuarter to 31 Mar 2024: revenue $662.1M, net income -$101.0MQuarter to 30 Jun 2024: revenue $662.4M, net income -$138.4MQuarter to 30 Jun 2024: revenue $662.4M, net income -$138.4MQuarter to 30 Sep 2024: revenue $674.9M, net income -$27.9MQuarter to 30 Sep 2024: revenue $674.9M, net income -$27.9MQuarter to 31 Mar 2025: revenue $651.3M, net income -$562.9MQuarter to 31 Mar 2025: revenue $651.3M, net income -$562.9MQuarter to 30 Jun 2025: revenue $710.3M, net income -$374.9MQuarter to 30 Jun 2025: revenue $710.3M, net income -$374.9MQuarter to 30 Sep 2025: revenue $701.3M, net income -$15.9MQuarter to 30 Sep 2025: revenue $701.3M, net income -$15.9MQuarter to 31 Mar 2026: revenue $636.5M, net income -$23.6MQuarter to 31 Mar 2026: revenue $636.5M, net income -$23.6MQuarter to 30 Jun 2026: revenue $678.2M, net income -$13.2MQuarter to 30 Jun 2026: revenue $678.2M, net income -$13.2MQuarter to 30 Sep 2026: revenue $691.5M, net income $600KQuarter to 30 Sep 2026: revenue $691.5M, net income $600K
31 Mar 2022RevenueNet incomeNet losstallest bar $793.1M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$691.5M$600K
30 Jun 2026$678.2M-$13.2M
31 Mar 2026$636.5M-$23.6M
30 Sep 2025$701.3M-$15.9M
30 Jun 2025$710.3M-$374.9M
31 Mar 2025$651.3M-$562.9M
30 Sep 2024$674.9M-$27.9M
30 Jun 2024$662.4M-$138.4M
31 Mar 2024$662.1M-$101.0M
31 Dec 2023$775.4M-$36.0M
30 Sep 2023$776.4M-$13.1M
30 Jun 2023$793.0M$28.3M
31 Mar 2023$693.9M$17.4M
31 Dec 2022$761.7M$33.4M
30 Sep 2022$762.3M$60.6M
30 Jun 2022$793.1M$66.4M
31 Mar 2022–$32.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.7B $2.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -3.4% +17%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$68.7M -$1.0B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.63 -$11.24
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 33.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 0.5% -33.1% -8.2%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -2.6% -36.8% -5.9%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -12.3% -10.1%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $169.0M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $220.6M $131.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.1B $1.1B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $834.7M $995.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 2.0 0.16
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $5.52
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 29.1
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.67 3.6
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.98 2.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.4 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
FortreaFTRE (this company) $1.8Bloss0.67-3.4%-2.6%
VeracyteVCYT $2.0B16.03.5+17%21.8%
PersonalisPSNL $1.5Bloss19.2+17%-148%
Lumexa ImagingLMRI $1.4B––––
CelcuityCELC $2.6Bloss–––
FreenomeFRNM $1.0Bloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$57K

bought $0, sold $57K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.9%

344 13F filers vs 328

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

102.1M shares held by 13F filers (30 Sep 2026) of 96.5M outstanding (27 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

8.9%

8.6M shares sold short (30 Oct 2026) of 96.5M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.7

8.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+12%

7.7M shares sold short in the report before, 8.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

332

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-1.4%

$691.5M vs $701.3M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+14%

$8.3M vs $7.3M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

15

15 articles in the last 7 days; its usual week has 1.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

10×

15 articles in the last 7 days; its usual week has 1.5.

Price $18.55 on 20 Nov 2026, +85% over 12 months (12-month range $8.87 to $25.88)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $4.7M in the last 12 months (the 12 months before: -$54K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $691.5M in the latest quarter, -1.4% on a year earlier.
Capital spending per quarter. Capital spending $8.3M in the latest quarter, +14% on a year earlier.
Institutional holders (13F filers). 344 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
30 Sep 20268-K and other filingsDirector or officer change
10 Sep 20268-K and other filingsDirector or officer change
29 Jul 20268-K and other filingsDirector or officer change
14 Jul 20268-K and other filingsDirector or officer change
26 Jun 20268-K and other filingsDirector or officer change
26 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Sep 20258-K and other filingsDirector or officer change
27 Aug 20258-K and other filingsDirector or officer change
29 Jul 2025Sharp changeShort interest spike: short interest spike, 14.3M vs usual 7.3M (2025-07-15); 1.6x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 14.9M vs usual 7.3M (2025-06-13); 1.7x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 13.5M vs usual 7.3M (2025-05-30); 1.7x the same period a year earlier
12 Jun 20258-K and other filingsDirector or officer change
11 Jun 20258-K and other filingsDirector or officer change
3 Jun 2025Sharp changeShort interest spike: short interest spike, 12.3M vs usual 7.1M (2025-05-15); 2.2x the same period a year earlier
12 May 20258-K and other filingsDirector or officer change
10 Mar 20258-K and other filingsDirector or officer change
21 Feb 20258-K and other filingsDirector or officer change
21 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 2024Sharp changeShort interest spike: short interest spike, 8.9M vs usual 4.7M (2024-07-15); 2.2x the same period a year earlier
11 Jul 20248-K and other filingsDirector or officer change
16 May 20248-K and other filingsDirector or officer change
15 May 20248-K and other filingsReport will be filed late
1 Apr 20248-K and other filingsDirector or officer change
1 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Aug 20238-K and other filingsDirector or officer change
3 Jul 20238-K and other filingsDirector or officer change
21 Jun 20238-K and other filingsDirector or officer change
21 Jun 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Aug 2023: $783K published
Month from 1 May 2024: $248K published
Month from 1 Jun 2024: $51K published
Month from 1 Jan 2025: -$203K published
Month from 1 Feb 2025: -$34K published
Month from 1 Mar 2025: -$49K published
Month from 1 Jun 2025: -$35K published
Month from 1 Aug 2025: $329K published
Month from 1 Sep 2025: -$61K published
Month from 1 Feb 2026: -$29K published
Month from 1 Mar 2026: -$138K published
Month from 1 May 2026: -$27K published
Month from 1 Jun 2026: -$229K published
Month from 1 Aug 2026: -$4.2M published
Month from 1 Sep 2026: -$57K published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 2 published
Revenue per quarter
Quarter ended 30 Jun 2022: $793.1M; public on 15 Aug 2023
Quarter ended 30 Sep 2022: $762.3M; public on 14 Nov 2023
Quarter ended 31 Dec 2022: $761.7M; public on 14 Mar 2024
Quarter ended 31 Mar 2023: $693.9M; public on 25 May 2024
Quarter ended 30 Jun 2023: $793.0M, 0% on a year earlier; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $776.4M, +1.8% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $775.4M, +1.8% on a year earlier; public on 14 Mar 2024
Quarter ended 31 Mar 2024: $662.1M, -4.6% on a year earlier; public on 25 May 2024
Quarter ended 30 Jun 2024: $662.4M, -16% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $674.9M, -13% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Mar 2025: $651.3M, -1.6% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $710.3M, +7.2% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $701.3M, +3.9% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Mar 2026: $636.5M, -2.3% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $678.2M, -4.5% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $691.5M, -1.4% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 30 Sep 2022: $17.0M; public on 14 Nov 2023
Quarter ended 31 Dec 2022: $18.4M; public on 14 Mar 2024
Quarter ended 31 Mar 2023: $16.2M; public on 25 May 2024
Quarter ended 30 Jun 2023: $9.6M; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $5.1M, -70% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $9.4M, -49% on a year earlier; public on 14 Mar 2024
Quarter ended 31 Mar 2024: $9.3M, -43% on a year earlier; public on 25 May 2024
Quarter ended 30 Jun 2024: $11.2M, +17% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $8.2M, +61% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Mar 2025: $2.9M, -69% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $7.5M, -33% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $7.3M, -11% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $7.5M; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $8.0M, +176% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $9.0M, +20% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $8.3M, +14% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
30 Jun 2023 report: 30; public on 14 Aug 2023
30 Sep 2023 report: 375; public on 14 Nov 2023
31 Dec 2023 report: 406; public on 14 Feb 2024
31 Mar 2024 report: 399; public on 15 May 2024
30 Jun 2024 report: 363; public on 14 Aug 2024
30 Sep 2024 report: 326; public on 14 Nov 2024
31 Dec 2024 report: 337; public on 14 Feb 2025
31 Mar 2025 report: 342; public on 15 May 2025
30 Jun 2025 report: 323; public on 14 Aug 2025
30 Sep 2025 report: 311; public on 14 Nov 2025
31 Dec 2025 report: 332; public on 17 Feb 2026
31 Mar 2026 report: 321; public on 15 May 2026
30 Jun 2026 report: 328; public on 14 Aug 2026
30 Sep 2026 report: 344; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is operating income, fiscal year at -$872.6M (31 Dec 2025), 1084% below its normal quarter of $88.7M; higher than 20% of its own history.
  • Insider net buying (open market): Insiders sold a net $4.7M in the last 12 months (the 12 months before: -$54K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $691.5M in the latest quarter, -1.4% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 45 insider trades

Last 90 days: 2 sales, $57K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
10 Sep 2026Carrie Elizabeth RussellInterim CAOSellafter exercising options246$16.85$4KForm 4
10 Sep 2026Mark A. MoraisChief Operating OfficerSellafter exercising options3,149$16.85$53KForm 4
19 Aug 2026Mark A. MoraisChief Operating OfficerSellafter exercising options4,892$18.19$89KForm 4
7 Aug 2026Anshul ThakralChief Executive OfficerSell111,857$18.11$2.0MForm 4
6 Aug 2026Anshul ThakralChief Executive OfficerSellafter exercising options99,869$19.16$1.9MForm 4
5 Aug 2026Machelle SandersDirectorSell9,700$18.01$175KForm 4
12 Jun 2026Mark A. MoraisChief Operating OfficerSell4,674$16.82$79KForm 4
3 Jun 2026Jill G. McConnellChief Financial OfficerSellafter exercising options4,866$15.49$75KForm 4

344 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 48 opened a position, 33 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.16.6M17.2%$331.2M+804K+5.1%
Goldman Sachs Group Inc8.5M8.85%$170.4M+129K+1.5%
Sessa Capital IM, L.P.4.6M4.76%$91.6MNo change
Vanguard Capital Management LLC4.2M4.32%$83.1M-15K-0.4%
Vanguard Portfolio Management LLC3.9M4.05%$78.0M+94K+2.5%
FMR LLC (Fidelity)3.8M3.94%$75.9M+159K+4.4%
State Street Corp3.8M3.93%$75.7M+12K+0.3%
AQR Capital Management LLC2.6M2.69%$50.9M-384K-13%
Geode Capital Management, LLC2.5M2.57%$49.6M-63K-2.5%
Loomis Sayles & Co L P2.5M2.57%$49.5M+42K+1.7%

Company events

All 24 company events

In 12 months: 5 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
30 Sep 2026Director or officer change8-K
10 Sep 2026Director or officer change8-K
29 Jul 2026Director or officer change8-K
14 Jul 2026Director or officer change8-K
26 Jun 2026Director or officer change8-K
22 Sep 2025Director or officer change8-K
27 Aug 2025Director or officer change8-K
12 Jun 2025Signed a major agreementSame filing: changed shareholder rights, changed its bylaws or fiscal year8-K

332 open postings; careers site tracked since 21 Nov 2026. Most in Research & science 16%, Data & analytics 7%, Program & project management 4%, Finance & accounting 3%.

PostedJobLocation
20 Nov 2026Intern IT Product (Commercial)Corporate ITWarsaw
20 Nov 2026Study Start Up ManagerMaidenhead
20 Nov 2026CRA II & Sr. CRA - General MedicineRemote United States; Remote Arizona; Remote California; Remote Colorado; Remote Florida; Remote Idaho; Remote Illinois; Remote Kansas; Remote Maine; Remote Massachusetts; Remote Missouri; Remote Nevada; Remote New Jersey; Remote New Mexico; Remote New York; Remote North Dakota; Remote Oregon; Remote South Dakota; Remote Tennessee; Remote Texas; Remote Virginia; Remote Washington; Remote West Virginia
20 Nov 2026Senior Programmer Analyst (Custom Function Programming)Software engineeringBangalore; Remote India
20 Nov 2026Senior Site Budget & Contract Maintenance Specialist - FSPBudapest
20 Nov 2026Therapeutic Strategy LeaderSales & business developmentShanghai
20 Nov 2026Senior Start Up Maintenance Specialist - Sponsor DedicatedMilan
20 Nov 2026Centralized Study Specialist II, Remote US or CanadaDurham; Remote Canada; Remote United States

The 5 newest of 127 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 30 Sep 2026Filings record

    Director or officer change

  2. 10 Sep 2026Filings record

    Director or officer change

  3. 29 Jul 2026Filings record

    Director or officer change

  4. 14 Jul 2026Filings record

    Director or officer change

  5. 26 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 26 Jun 2026Filings record

    Director or officer change

  7. 22 Sep 2025Filings record

    Director or officer change

  8. 5 Sep 2025Insiders record

    Russell Erin L (director) bought 9,854 shares of FTRE ($100,018) (dated 4 Sep 2025)

  9. 27 Aug 2025Filings record

    Director or officer change

  10. 12 Aug 2025Insiders record

    NEUPERT PETER M (director) bought 62,500 shares of FTRE ($407,150) (dated 11 Aug 2025)

  11. 25 Jul 2025Short interest and volume change

    had 14.3M shares sold short in the 15 Jul 2025 report, 1.6× the same report last year.

    Same report last year: 8.9M; its normal report is 7.3M.

    See the evidence
    This period
    14.3M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +4.2
    Same report last year
    8.9M
    History used
    732 days
    2024-07-15: 8.9M2024-07-31: 8.1M2024-08-15: 6.7M2024-08-30: 6.1M2024-09-13: 7.4M2024-09-30: 7.3M2024-10-15: 7.3M2024-10-31: 7.2M2024-11-15: 5.5M2024-11-29: 5.3M2024-12-13: 5.3M2024-12-31: 5.7M2025-01-15: 5.9M2025-01-31: 6.1M2025-02-14: 7.3M2025-02-28: 6.9M2025-03-14: 7.9M2025-03-31: 6.1M2025-04-15: 6.1M2025-04-30: 8.3M2025-05-15: 12.3M2025-05-30: 13.5M2025-06-13: 14.9M2025-06-30: 15.3M2025-07-15: 14.3M
    the 15 Jul 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 26 Jun 2025Short interest and volume change

    had 14.9M shares sold short in the 13 Jun 2025 report, 1.7× the same report last year.

    Same report last year: 9.0M; its normal report is 7.3M.

    See the evidence
    This period
    14.9M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +4.6
    Same report last year
    9.0M
    History used
    700 days
    2024-06-14: 9.0M2024-06-28: 9.4M2024-07-15: 8.9M2024-07-31: 8.1M2024-08-15: 6.7M2024-08-30: 6.1M2024-09-13: 7.4M2024-09-30: 7.3M2024-10-15: 7.3M2024-10-31: 7.2M2024-11-15: 5.5M2024-11-29: 5.3M2024-12-13: 5.3M2024-12-31: 5.7M2025-01-15: 5.9M2025-01-31: 6.1M2025-02-14: 7.3M2025-02-28: 6.9M2025-03-14: 7.9M2025-03-31: 6.1M2025-04-15: 6.1M2025-04-30: 8.3M2025-05-15: 12.3M2025-05-30: 13.5M2025-06-13: 14.9M
    the 13 Jun 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 12 Jun 2025Filings record

    Director or officer change

  14. 11 Jun 2025Short interest and volume change

    had 13.5M shares sold short in the 30 May 2025 report, 1.7× the same report last year.

    Same report last year: 8.1M; its normal report is 7.3M.

    See the evidence
    This period
    13.5M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +3.7
    Same report last year
    8.1M
    History used
    686 days
    2024-05-31: 8.1M2024-06-14: 9.0M2024-06-28: 9.4M2024-07-15: 8.9M2024-07-31: 8.1M2024-08-15: 6.7M2024-08-30: 6.1M2024-09-13: 7.4M2024-09-30: 7.3M2024-10-15: 7.3M2024-10-31: 7.2M2024-11-15: 5.5M2024-11-29: 5.3M2024-12-13: 5.3M2024-12-31: 5.7M2025-01-15: 5.9M2025-01-31: 6.1M2025-02-14: 7.3M2025-02-28: 6.9M2025-03-14: 7.9M2025-03-31: 6.1M2025-04-15: 6.1M2025-04-30: 8.3M2025-05-15: 12.3M2025-05-30: 13.5M
    the 30 May 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 11 Jun 2025Filings record

    Director or officer change

  16. 28 May 2025Short interest and volume change

    had 12.3M shares sold short in the 15 May 2025 report, 2.2× the same report last year.

    Same report last year: 5.7M; its normal report is 7.1M.

    See the evidence
    This period
    12.3M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    7.1M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +3.5
    Same report last year
    5.7M
    History used
    671 days
    2024-05-15: 5.7M2024-05-31: 8.1M2024-06-14: 9.0M2024-06-28: 9.4M2024-07-15: 8.9M2024-07-31: 8.1M2024-08-15: 6.7M2024-08-30: 6.1M2024-09-13: 7.4M2024-09-30: 7.3M2024-10-15: 7.3M2024-10-31: 7.2M2024-11-15: 5.5M2024-11-29: 5.3M2024-12-13: 5.3M2024-12-31: 5.7M2025-01-15: 5.9M2025-01-31: 6.1M2025-02-14: 7.3M2025-02-28: 6.9M2025-03-14: 7.9M2025-03-31: 6.1M2025-04-15: 6.1M2025-04-30: 8.3M2025-05-15: 12.3M
    the 15 May 2025 report24 earlier reportsnormal: 7.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 12 May 2025Filings record

    Director or officer change

  18. 10 Mar 2025Filings record

    Director or officer change

  19. 21 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 21 Feb 2025Filings record

    Director or officer change

  21. 25 Jul 2024Short interest and volume change

    had 8.9M shares sold short in the 15 Jul 2024 report, 2.2× the same report last year.

    Same report last year: 4.0M; its normal report is 4.7M.

    See the evidence
    This period
    8.9M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    4.7M
    Typical spread (median absolute deviation)
    664K
    How far from its usual level
    +4.3
    Same report last year
    4.0M
    History used
    367 days
    2023-07-14: 4.0M2023-07-31: 4.3M2023-08-15: 4.2M2023-08-31: 3.0M2023-09-15: 2.1M2023-09-29: 2.7M2023-10-13: 3.2M2023-10-31: 3.7M2023-11-15: 4.0M2023-11-30: 4.3M2023-12-15: 4.8M2023-12-29: 4.8M2024-01-12: 5.0M2024-01-31: 6.0M2024-02-15: 5.2M2024-02-29: 4.1M2024-03-15: 5.3M2024-03-28: 4.6M2024-04-15: 4.7M2024-04-30: 6.6M2024-05-15: 5.7M2024-05-31: 8.1M2024-06-14: 9.0M2024-06-28: 9.4M2024-07-15: 8.9M
    the 15 Jul 2024 report24 earlier reportsnormal: 4.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 11 Jul 2024Filings record

    Director or officer change

  23. 13 Jun 2024Insiders record

    Hanson James S. (General Counsel) bought 2,000 shares of FTRE ($50,600) (dated 12 Jun 2024)

  24. 31 May 2024Insiders record

    Pike Thomas (Chief Executive Officer) bought 10,000 shares of FTRE ($248,100) (dated 30 May 2024)

  25. 16 May 2024Filings record

    Director or officer change

  26. 15 May 2024Filings record

    Report will be filed late

  27. 1 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 1 Apr 2024Filings record

    Director or officer change

  29. 14 Nov 2023Institutional holdings record

    VANGUARD GROUP INC opened a $286.0M position (2023Q3 13F)

  30. 13 Nov 2023Institutional holdings record

    BlackRock Inc. opened a $484.0M position (2023Q3 13F)

  31. 24 Aug 2023Insiders record

    Pike Thomas (Chief Executive Officer) bought 20,000 shares of FTRE ($504,600) (dated 23 Aug 2023)

  32. 24 Aug 2023Insiders record

    NEUPERT PETER M (director) bought 11,000 shares of FTRE ($278,300) (dated 23 Aug 2023)

  33. 21 Aug 2023Filings record

    Director or officer change

  34. 3 Jul 2023Filings record

    Director or officer change

  35. 21 Jun 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 21 Jun 2023Filings record

    Director or officer change

Not listed: 77 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001965040
Ticker
FTRE
Domain
fortrea.com
Employer name
fortrea, fortrea inc f k a labcorp drug development, fortrea inc formely d b a labcorp drug development, fortrea inc formerly d b a labcorp drug development and 1 more (1 unverified)
Hq location
NC|DURHAM|27709 (1 unverified)
Name
Chiltern International Limited (CIL), Fortrea Argentina S.A, Fortrea Asia-Pacific Inc, Fortrea Australia Pty Ltd and 76 more
  • DOL H-1B labor condition applications and PERM certifications22 data points17 Nov 2025 to 7 Sep 2026
  • SEC Form 13F institutional holdings2 records, 126 data points30 Jun 2023 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)57 records21 Jun 2023 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)254 data points31 Dec 2020 to 27 Oct 2026
  • SEC Form 4 insider transactions45 records, 104 data points23 Aug 2023 to 10 Sep 2026
  • FINRA short interest (twice monthly)240 data points14 Jul 2023 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1704 data points3 Jul 2023 to 20 Nov 2026